LONDON, UK. 9th February 2026 – HMDG, a healthcare marketing and strategy company operating within the private healthcare and musculoskeletal (MSK) sector, has formally established an independent Advisory Board to strengthen clinical oversight, ethical standards, and long-term decision-making as the business continues to scale.
The formation of the Advisory Board formalises a governance structure that has existed informally since the company’s inception. HMDG has historically relied on senior clinicians and experienced industry figures to review ideas, challenge internal assumptions, and provide external scrutiny before initiatives were launched. The new Advisory Board introduces a defined and accountable framework for this process.
HMDG was founded with a clinical background at its core, and the business has consistently employed clinicians and sector specialists alongside its commercial team. Over time, leadership concluded that informal consultation was no longer sufficient for a company operating at national scale within healthcare. The Advisory Board has been established to provide independent guidance and structured challenge as part of HMDG’s long-term governance approach.
The Advisory Board has been assembled to support several defined objectives. These include reviewing new initiatives prior to market release, acting as a critical sounding board for senior leadership, challenging assumptions within the organisation, and ensuring strategic decisions remain aligned with clinical standards, patient outcomes, and ethical practice.
Jack Chew, a long-standing clinical advisor to the business, was asked to assist in assembling a small group of senior figures with direct experience across clinical delivery, operations, leadership, and healthcare technology.
The Advisory Board includes Lucy Macdonald, a physiotherapist and healthcare leader with experience building and exiting private clinics. She is currently Lead Physiotherapist and Founding Director of Restart Physio in Surrey and holds additional non-executive, consultancy, and media roles within healthcare.
Nicola Graham also joins the Advisory Board, bringing experience across NHS practice, elite sport, and private healthcare. She has previously owned and exited a multidisciplinary healthcare business and now operates in fractional and board roles across preventative health, human performance, and sports technology, following completion of an Executive MBA.
Ove Indergaard, founder and Chief Executive of Indergaard Physiotherapy Ltd, contributes nearly three decades of experience in MSK care. He leads a multi-site clinic group in the north of England and is recognised internationally for his work in Shockwave Therapy education and clinical standards.
Laura Beaven completes the Advisory Board. A chiropractor by training, she is co-founder and Chief Operating Officer of Dyer Street Clinic, where she played a central role in scaling the organisation from a small practice into a multidisciplinary clinic employing more than 20 staff.
Commenting on the formation of the Advisory Board, Ben Marcilhacy HMDG CEO said: “As HMDG has grown, so has its responsibility to the sector. The Advisory Board exists to ensure decisions are challenged, standards remain high, and the business continues to act in a way that is clinically credible and ethically grounded.”
The company has stated that the Advisory Board is intended as a permanent governance structure rather than a short-term initiative, with an emphasis on transparency, accountability, and continuous improvement.
About HMDG
HMDG is a healthcare marketing and strategy company specialising in the private healthcare and MSK sector. The business works with clinic owners to develop sustainable growth strategies that are aligned with clinical standards, patient outcomes, and long-term operational viability.
ENDS